{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443384468
| IUPAC_name = 4-Dimethylamino-1,5-dimethyl-2-phenylpyrazol-3-one
| image = Aminophenazone-2d-skeletal.png
| width = 180px
| image2 = Aminophenazone-3D-balls.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|aminophenazone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = N-demethylation<ref name="Caubet2007">{{cite journal|last1=Caubet|first1=M. S.|last2=Laplante|first2=A.|last3=Caillé|first3=J.|last4=Brazier|first4=J. L.|title=[13C]Aminopyrine and [13C]Caffeine Breath Test: Influence of Gender, Cigarette Smoking and Oral Contraceptives Intake|journal=Isotopes in Environmental and Health Studies|volume=38|issue=2|date=4 Jan 2007|pages=71–77|doi=10.1080/10256010208033314}}</ref>
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 58-15-1
| ATC_prefix = N02
| ATC_suffix = BB03
| PubChem = 6009
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01424
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5787
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 01704YP3MO
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00556
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 160246
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 288470
<!--Chemical data-->
| C=13 | H=17
| N=3 | O=1
| molecular_weight = 231.29358
| smiles = O=C2\C(=C(/N(N2c1ccccc1)C)C)N(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RMMXTBMQSGEXHJ-UHFFFAOYSA-N
}}

'''Aminophenazone''' (or '''aminopyrine''') is a [[pyrazolone]] with analgesic, anti-inflammatory, and antipyretic properties but has risk of [[agranulocytosis]]. A breath test with [[Carbon-13|<sup>13</sup>C]]-labeled aminopyrine has been used as a non-invasive measure of [[cytochrome]] P-450 metabolic activity in liver function tests.<ref name="Caubet2007" /> It is also used in measuring the total body water in the human body system.<ref>{{cite web
| date=2005-03-26
| url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6009&loc=ec_rcs
| title=Aminophenazone — Compound Summary
| work=PubChem
| publisher=The National Library of Medicine
| accessdate=June 12, 2008
| description=
}}</ref>

== References ==
{{reflist}}

{{Analgesics}}

[[Category:Pyrazolones]]
[[Category:Analgesics]]
[[Category:Antipyretics]]
[[Category:Nonsteroidal anti-inflammatory drugs]]

{{analgesic-stub}}